Biomarker: T008-IgE Elm, American

Overview

T008-IgE Elm, American measures serum-specific immunoglobulin E antibodies directed against pollen from the American elm tree (Ulmus americana). IgE is an antibody involved in allergic immune responses, including recognition of inhaled pollen and activation of mast cells and basophils. A detectable or elevated result indicates sensitization to the tested elm pollen extract, but does not by itself confirm symptomatic allergy or predict reaction severity. The test supports evaluation of seasonal allergic rhinitis, conjunctivitis, and asthma when interpreted with the patient’s symptoms and exposure history.

Clinical Use Cases

Evaluating suspected seasonal allergic rhinitis or hay fever associated with tree-pollen exposure.
Supporting assessment of allergic conjunctivitis or pollen-associated asthma.
Identifying sensitization to elm pollen as part of an environmental allergy panel.
Helping guide allergen avoidance and consideration of allergen immunotherapy.
Providing an alternative to skin-prick testing when skin disease, medication use, age, or risk of systemic reaction limits skin testing.

Specimen Types

Venous blood, typically collected as serum.
Plasma may be accepted by some validated assay systems, according to the testing laboratory’s requirements.

Measurement Methods

Serum-specific IgE immunoassay using an immobilized American elm pollen extract.
Fluorescence enzyme immunoassay or other automated solid-phase immunoassay platforms.
Enzyme-linked immunosorbent assay methods.
Skin-prick testing with an elm pollen extract is a related clinical assessment but does not measure serum T008-specific IgE directly.

Test Preparation and Influencing Factors

Fasting is generally not required for a serum-specific IgE blood test.
Patients should report antihistamines, corticosteroids, biologic medicines, and other medications. Medication changes should occur only under clinical guidance.
Results should be interpreted with symptom timing, geographic exposure, pollen season, and physical findings.
A positive result indicates immunologic sensitization and does not establish that exposure causes symptoms or indicate symptom severity.
Total IgE, smoking, parasitic infection, and other allergic or inflammatory conditions can influence overall IgE concentrations, although they do not specifically establish American elm allergy.
Assay cutoff values and reporting categories vary by method. Results from different platforms should not be compared without considering their reference systems.
Cross-reactivity among tree pollens may contribute to positive results and should be considered during clinical interpretation.